Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest

Phosphorylation/inactivation of RB is typically required for cell cycle pro gression. However, we have identified a tumor cell line, C33A, which progre sses through the cell cycle in the presence of an active allele of RB (PSM- RB), To determine how C33A cells evade RB-mediated arrest, we compared RB s ignaling to downstream effecters in this resistant cell line to that of the RB-sensitive SAOS-2 cell line. Although introduction of PSM-RB repressed E 2F-mediated transcription in both C33A and SAOS-2 cells, PSM-RB failed to r epress Cyclin A promoter activity in C33A, Ectopic expression of PSM-RB in SAOS-2 cells resulted in a decrease in both Cyclin A and Cdk2 protein level s without affecting Cyclin E or Cdk4, In contrast, over-expression of PSM-R B in C33A cells did not alter endogenous Cyclin A, Cyclin E, or Cdk2 protei n levels or impact Cdk2 kinase activity, indicating that signaling from RB to downstream targets is abrogated in this cell line. The importance of Cdk 2 activity was demonstrated by p27Kip1, which attenuated Cdk2 activity and inhibited cell cycle progression in C33A cells, Since RB signaling to Cdk2 is disrupted in these tumor cells, we coexpressed two proteins that coopera te with RB transcriptional repression, AHR and BRG-1, in an attempt to corr ect this signaling dysfunction, Coexpression of AHR/BRG-1 with PSM-RB atten uated Cyclin A and Cdk2 expression as well as Cdk2-associated kinase activi ty, resulting in cell cycle inhibition of C33A cells. Importantly, ectopic expression of Cyclin A was able to reverse the arrest mediated by co-expres sion of AHR/BRG-1 with PSM-RB, These results indicate that down-regulation of Cdk2 activity is requisite for RB-mediated cell cycle arrest. Thus, this study reveals a new mechanism through which tumor cells evade anti-prolife rative signals, and provides insight into how RB-signaling is mediated.